货号:GS40143
Cofetuzumab (also known as PF-06647020) is an investigational antibody-drug conjugate (ADC) developed for the treatment of solid tumors. It is designed to deliver a potent cytotoxic agent specifically to cancer cells that overexpress a particular tumor-associated antigen, thereby aiming to maximize anti-tumor efficacy while limiting systemic toxicity. Clinical trials have evaluated its safety and preliminary efficacy in patients with advanced cancers, including platinum-resistant ovarian cancer and triple-negative breast cancer.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物